HepatologyConference recording2025
Houston Methodist Emerging Topics in Liver Disease 2025 — MASLD, liver cancer and the future of transplantation
The Houston Methodist Emerging Topics in Liver Disease Conference 2025, recorded on 20–21 September 2025, gives hepatology’s hardest current questions a weekend’s worth of attention. Eighteen recordings move from coagulopathy and drug injury in cirrhosis to the metabolic liver epidemic, artificial intelligence, living donation and immunotherapy for hepatocellular carcinoma, with four panel Q&As in which national and guest faculty debate the grey areas.
- 18sessions
- 4panel Q&As
- 2days
- 2025edition
What you’ll be able to do
- Recognise drug-induced liver injury in a liver that is already diseased
- Manage bleeding and coagulopathy in cirrhosis and unusual portal hypertension complications
- Stage fibrosis non-invasively and choose current and upcoming MASLD therapies
- Handle MASLD overlapping with alcohol-related disease, HBV or HCV
- Apply modern HCC surveillance, diagnosis and immunotherapy
- Explain where living donor transplant and transplant for cholangiocarcinoma and other tumours now fit
Inside the course
Cirrhosis complications
DILI in chronic disease, haemostasis in cirrhosis and emerging threats for liver cancer prevention, closing with a portal hypertension panel.
Emerging topics in liver disease: MASLD
Endocrine and obesity aspects, non-invasive fibrosis testing, the treatment pipeline and dual-aetiology patients are followed by a panel on what is new.
Transplant and innovation
The 2025 transplant outlook, AI in hepatology, a new era for living donation and transplantation for cholangiocarcinoma.
Liver cancer
Surveillance and diagnosis of HCC, immunotherapy, the widening list of transplantable tumours and a final concepts panel.
Built for
- Hepatologists and gastroenterologistsA concentrated review of what changed in 2025.
- Endocrinologists and internistsMetabolic liver disease sessions directly relevant to their patients.
- Transplant teams and oncologistsDonor, tumour and immunotherapy updates in one package.
Faculty & syllabus
Programme 18 sessions
- Drug-Induced Liver Injury in the Patient with Chronic Liver Disease
- Management of Coagulopathy & Bleeding Diathesis in Cirrhosis
- From Risk to Recognition: Addressing Emerging Threats to Improve Prevention and Detection of HCC
- Unique Complications of Portal Hypertension (Panel Q&A)
- Endocrine Aspects of MASLD & Obesity: 2025 Update
- Noninvasive Assessment of Fibrosis in MASLD
- Current and Future Treatment Options of MASLD
- The Patient with MASLD and Concomitant Alcohol-Associated Liver Disease, HBV, or HCV – What to Do?
- Advances in MASLD – What’s New? (Panel Q&A)
- The Future of Liver Transplantation in 2025
- Role of Artificial Intelligence (AI) in the Management of Liver Disease
- Living Donor Liver Transplant – A New Era
- The Role of Liver Transplantation in the Management of Cholangiocarcinoma
- Current Innovations in Liver Disease (Panel Q&A)
- Surveillance & Diagnosis of Hepatocellular Cancer – What Is New?
- Management of Hepatocellular Carcinoma – Role of Immunotherapy
- Expanding Role of Transplantation for Rare and Not-So-Rare Tumors
- Liver Cancer – Current Concepts (Panel Q&A)
Before you buy
Are running times, speakers or file sizes given?
No. The programme lists session titles only; it is supplied as video recordings, and slides are not mentioned.
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Video recordings |
|---|---|
| Dates | 20–21 September 2025 |
| Contents | 18 sessions incl. 4 panels |
| Publisher | Houston Methodist |
| Department | Gastroenterology |
| Delivery | Instant download · lifetime re-download |
Related products
Critical Care / Emergency Medicine
Cleveland Clinic International Perspectives on Liver Failure in Critical Care 2025
